Published in Infect Immun on June 01, 2001
The role of infections in autoimmune disease. Clin Exp Immunol (2009) 1.47
Streptococcus and rheumatic fever. Curr Opin Rheumatol (2012) 1.32
Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology (2012) 1.23
Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann Pediatr Cardiol (2011) 1.17
Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am J Pathol (2002) 1.13
Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J Autoimmun (2012) 1.05
Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis. Am J Pathol (2001) 1.02
Protection against or triggering of Type 1 diabetes? Different roles for viral infections. Expert Rev Clin Immunol (2011) 0.99
A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun (2004) 0.97
B- and T-cell responses in group a streptococcus M-protein- or Peptide-induced experimental carditis. Infect Immun (2009) 0.94
Animal models to investigate the pathogenesis of rheumatic heart disease. Front Pediatr (2014) 0.88
A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun (2002) 0.87
Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha. Am J Pathol (2010) 0.87
Autoimmune myocarditis, valvulitis, and cardiomyopathy. Curr Protoc Immunol (2013) 0.83
Relevance of molecular mimicry in the mediation of infectious myocarditis. J Cardiovasc Transl Res (2013) 0.83
Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int Rev Immunol (2014) 0.83
Identification of streptococcal m-protein cardiopathogenic epitopes in experimental autoimmune valvulitis. J Cardiovasc Transl Res (2013) 0.83
An animal model of chronic rheumatic valvulitis induced by formalin-killed streptococci. Rheumatol Int (2009) 0.81
Anti-endothelial cell antibodies in rheumatic heart disease. Clin Exp Immunol (2010) 0.78
Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity. Clin Rheumatol (2014) 0.78
Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease. Autoimmunity (2016) 0.76
Proteomic analysis of mitral valve in Lewis rat with acute rheumatic heart disease. Int J Clin Exp Pathol (2015) 0.75
Unresolved issues in theories of autoimmune disease using myocarditis as a framework. J Theor Biol (2014) 0.75
Autoimmune valvular carditis. Curr Allergy Asthma Rep (2015) 0.75
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med (1987) 5.58
Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol (1989) 4.20
Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule. J Exp Med (1980) 2.75
Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol (1987) 2.65
Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr (1994) 2.52
Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol (1991) 2.20
A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol (1990) 1.88
Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci U S A (1985) 1.68
Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A (1992) 1.49
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis (2000) 1.31
Doppler echocardiography distinguishes between physiologic and pathologic "silent" mitral regurgitation in patients with rheumatic fever. Clin Cardiol (1997) 1.25
Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis. J Immunol (1996) 1.17
Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect Immun (1997) 1.11
A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-beta-D-glucosamine. J Immunol (1993) 1.10
Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci U S A (1992) 1.09
Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. J Immunol (1994) 1.08
Cytokeratin peptide SFGSGFGGGY mimics N-acetyl-beta-D-glucosamine in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response. J Immunol (1994) 1.05
Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine/anti-myosin antibody V region genes. J Immunol (1998) 1.04
Rheumatic fever. The relationships between host, microbe, and genetics. Rheum Dis Clin North Am (1998) 0.95
Enzymatic comparisons between light chain isozymes of human cardiac myosin subfragment-1. J Biol Chem (1984) 0.95
Molecular analysis of V gene sequences encoding cytotoxic anti-streptococcal/anti-myosin monoclonal antibody 36.2.2 that recognizes the heart cell surface protein laminin. J Immunol (1997) 0.95
Resurgence of rheumatic fever in the United States. The changing picture of a preventable illness. Postgrad Med (1992) 0.86
Ethnic differences in expression of susceptibility marker(s) in rheumatic fever/rheumatic heart disease patients. Int J Cardiol (1998) 0.84
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci U S A (1992) 6.95
Sorting of protein A to the staphylococcal cell wall. Cell (1992) 6.48
Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor. J Biol Chem (1986) 6.38
Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med (1992) 4.60
A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal Biochem (1994) 4.24
Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A (1988) 3.82
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science (2001) 3.72
Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69
Size variation of the M protein in group A streptococci. J Exp Med (1985) 3.45
alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem (1998) 3.37
Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats. Mol Gen Genet (1987) 3.32
Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med (1985) 3.23
Variation in the expression of cell wall proteins of Staphylococcus aureus grown on solid and liquid media. Infect Immun (1988) 3.21
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A (2001) 3.10
Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. J Exp Med (1986) 2.89
Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules. J Exp Med (1976) 2.77
Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule. J Exp Med (1980) 2.75
Purification and physical properties of group C streptococcal phage-associated lysin. J Exp Med (1971) 2.67
Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules. J Immunol (1980) 2.62
Expression of streptococcal M protein in Escherichia coli. Science (1983) 2.57
The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. J Exp Med (1988) 2.42
The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J Biol Chem (1984) 2.40
GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med (1997) 2.37
Isolation and characterization of the cell-associated region of group A streptococcal M6 protein. J Bacteriol (1988) 2.35
Myosin: a link between streptococci and heart. Science (1985) 2.28
Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet (2000) 2.24
Relationship of M protein genes in group A streptococci. Proc Natl Acad Sci U S A (1985) 2.24
Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun (1988) 2.24
Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol (1994) 2.23
Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med (1989) 2.15
Streptococcal M protein extracted by nonionic detergent. II. Analysis of the antibody response to the multiple antigenic determinants of the M-protein molecule. J Exp Med (1977) 2.13
A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation (1990) 2.05
Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03
Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science (1998) 2.02
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest (1999) 1.95
Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med (1994) 1.91
DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain. Infect Immun (1995) 1.91
Homologous regions within M protein genes in group A streptococci of different serotypes. Infect Immun (1986) 1.85
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood (2000) 1.80
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci U S A (1995) 1.80
Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region. J Immunol (1983) 1.79
Sequence and structural characteristics of the trypsin-resistant T6 surface protein of group A streptococci. J Bacteriol (1990) 1.78
Identification of an endogenous membrane anchor-cleaving enzyme for group A streptococcal M protein. Its implication for the attachment of surface proteins in gram-positive bacteria. J Exp Med (1989) 1.77
A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.77
Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme. Proc Natl Acad Sci U S A (1993) 1.76
Peptic digestion of streptococcal M protein. I. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts. Infect Immun (1974) 1.74
Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest (1991) 1.73
Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage (2000) 1.71
Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci U S A (1985) 1.68
Review and hypothesis: the eosinophil and peripartum heart disease (myocarditis and coronary artery dissection)--coincidence or pathogenetic significance? Cardiovasc Res (1997) 1.65
The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis (1990) 1.64
Immunochemical analysis of intact M protein secreted from cell wall-less streptococci. Infect Immun (1981) 1.62
Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A (1988) 1.62
Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol (2000) 1.60
WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. Proc Natl Acad Sci U S A (1995) 1.56
Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J Bacteriol (1997) 1.55
Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med (1996) 1.54
A human IgG receptor of group A streptococci is associated with tissue site of infection and streptococcal class. J Infect Dis (1990) 1.53
Nucleotide sequences of two adjacent M or M-like protein genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein. Infect Immun (1992) 1.53
Differentiation between two biologically distinct classes of group A streptococci by limited substitutions of amino acids within the shared region of M protein-like molecules. J Exp Med (1990) 1.52
The heart as a suction pump. Sci Am (1986) 1.52
Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Chemother (2003) 1.51
Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein. Infect Immun (1995) 1.50
Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol (1990) 1.50
Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A (1992) 1.49
Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol (1999) 1.49
Skeletal framework of mammalian heart muscle. Arrangement of inter- and pericellular connective tissue structures. Lab Invest (1983) 1.46
Induction of lysogenic bacteriophage and phage-associated toxin from group a streptococci during coculture with human pharyngeal cells. Infect Immun (2001) 1.46
Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest (2000) 1.46
Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res (1998) 1.44
A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. Proc Natl Acad Sci U S A (1999) 1.44
Myocardial micronecrosis produced by microsphere embolization. Role of an alpha-adrenergic tonic influence on the coronary microcirculation. Circ Res (1984) 1.43
Histological evaluation of the inferior epigastric artery in patients with known atherosclerosis. Eur J Cardiothorac Surg (1992) 1.43
Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation (1982) 1.41
Fibrous long-spacing collagen in bacillary angiomatosis. Ultrastruct Pathol (1998) 1.41
A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. Infect Immun (1987) 1.40
Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med (1988) 1.39
Biological and immunochemical identity of M protein on group G streptococci with M protein on group A streptococci. Infect Immun (1987) 1.39
Amino acid sequence and physicochemical similarities between streptococcal M protein and mammalian tropomyosin. Proc Natl Acad Sci U S A (1979) 1.38
A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J Immunol (1986) 1.37
High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci U S A (1992) 1.37
Antigenic domains of the streptococcal Pep M5 protein. Localization of epitopes crossreactive with type 6 M protein and identification of a hypervariable region of the M molecule. J Exp Med (1986) 1.34
Primary structure of streptococcal Pep M5 protein: Absence of extensive sequence repeats. Proc Natl Acad Sci U S A (1983) 1.33
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother (2005) 1.33
Delivery and expression of a heterologous antigen on the surface of streptococci. Infect Immun (1992) 1.32
The occurrence of a protein in the extracellular products of streptococci isolated from patients with acute glomerulonephritis. J Exp Med (1979) 1.31
Identification and characterization of a novel fibronectin-binding protein on the surface of group A streptococci. Infect Immun (1999) 1.31
Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever. J Clin Invest (1974) 1.31
Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis (2000) 1.31
Immunogenicity of glutaraldehyde-tanned bovine pericardium. J Thorac Cardiovasc Surg (1990) 1.30
Capillary microaneurysms in the human diabetic heart. N Engl J Med (1980) 1.28
Streptococcal M protein extracted by nonionic detergent. III. Correlation between immunological cross-reactions and structural similarities with implications for antiphagocytosis. J Exp Med (1978) 1.27
Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol (1989) 1.26
Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae. J Infect Dis (2000) 1.25
Study of heart-reactive antibody in antisera and hybridoma culture fluids against group A streptococci. Infect Immun (1983) 1.25